Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical & Experimental Metastasis|November 6, 2007
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancerGeert Berx, Eric Raspé, Gerhard Christofori, et al.Cancers|February 11, 2023
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and ChallengesTatjana Arsenijevic, Katia Coulonval, Eric Raspé, et al.Cell Cycle (Georgetown, Tex.)|December 16, 2021
Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27Katia Coulonval, Vincent Vercruysse, Sabine Paternot, et al.Journal of Lipid Research|November 28, 2002
Identification of Rev-erbalpha as a physiological repressor of apoC-III gene transcriptionEric Raspé, Hélène Duez, Anethe Mansén, et al.Cellular and Molecular Life Sciences : CMLS|January 6, 2012
Identification of putative cancer genes through data integration and comparative genomics between plants and humansMauricio Quimbaya, Klaas Vandepoele, Eric Raspé, et al.Neoplasia (New York, N.Y.)|September 24, 2014
Deregulation of the replisome factor MCMBP prompts oncogenesis in colorectal carcinomas through chromosomal instabilityMauricio Quimbaya, Eric Raspé, Geertrui Denecker, et al.EMBO Molecular Medicine|June 2, 2017
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclibEric Raspé, Katia Coulonval, Jaime M Pita, et al.Molecular Oncology|December 1, 2022
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibitionSabine Paternot, Eric Raspé, Clément Meiller, et al.Frontiers in Endocrinology|November 15, 2023
CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomasJaime M Pita, Eric Raspé, Katia Coulonval, et al.Pageof 1